Prevention of 5-fluorouracil-induced early severe toxicity by pre-therapeutic dihydropyrimidine dehydrogenase deficiency screening: Assessment of a multiparametric approach

MLA

Boisdron-Celle, Michele, et al. “Prevention of 5-Fluorouracil-Induced Early Severe Toxicity by Pre-Therapeutic Dihydropyrimidine Dehydrogenase Deficiency Screening: Assessment of a Multiparametric Approach.” Seminars in Oncology, vol. 44, no. 1, Feb. 2017, pp. 13–23. EBSCOhost, https://doi.org/10.1053/j.seminoncol.2017.02.008.

APA

Boisdron-Celle, M., Capitain, O., Faroux, R., Borg, C., Metges, J. P., Galais, M. P., Kaassis, M., Bennouna, J., Bouhier-Leporrier, K., Francois, E., Baumgaertner, I., Guerin-Meyer, V., Cojocarasu, O., Roemer-Becuwe, C., Stampfli, C., Rosenfeld, L., Lecompte, T., Berger, V., Morel, A., & Gamelin, E. (2017). Prevention of 5-fluorouracil-induced early severe toxicity by pre-therapeutic dihydropyrimidine dehydrogenase deficiency screening: Assessment of a multiparametric approach. Seminars in Oncology, 44(1), 13–23. https://doi.org/10.1053/j.seminoncol.2017.02.008

Chicago

Boisdron-Celle, Michele, Olivier Capitain, Roger Faroux, Christophe Borg, Jean Philippe Metges, Marie Pierre Galais, Mehdi Kaassis, et al. 2017. “Prevention of 5-Fluorouracil-Induced Early Severe Toxicity by Pre-Therapeutic Dihydropyrimidine Dehydrogenase Deficiency Screening: Assessment of a Multiparametric Approach.” Seminars in Oncology 44 (1): 13–23. doi:10.1053/j.seminoncol.2017.02.008.